NCT03665753View on ClinicalTrials.gov

Comparison of IV 10, 20, and 30mg for Renal Colic Pain in the ED

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

September 9, 2019

Study Completion Date

November 9, 2019

Conditions
PainRenal Colic
Interventions
DRUG

Ketorolac

Subject will receive 10, 20, and 30mg of Ketorolac.

Trial Locations (1)

Unknown

IKCH, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT03665753 - Comparison of IV 10, 20, and 30mg for Renal Colic Pain in the ED | Biotech Hunter | Biotech Hunter